Antimicrobial defence through competition for zinc

Reviews and Research in Medical Microbiology

Volumn 8, Issue 4, 1997, Pages 217-224

  Sohnle, Peter G ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Calcium binding protein; Calprotectin; Iron; Neutrophil; Zinc

Indexed keywords

CALCIUM BINDING PROTEIN; CALGRANULIN; CALPROTECTIN; LACTOFERRIN; TRANSFERRIN; ZINC;

ANTIMICROBIAL ACTIVITY; MICROBIAL GROWTH; NEUTROPHIL; PRIORITY JOURNAL; REVIEW;

EID: 0030845905     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199710000-00005     Document Type: Review

References (41)

1. Finkelstein RA, Sciortino CV, McIntosh MA. Role of iron in microbe-host interactions. Rev Infect Dis 1983; 5: S759-S777.
2. Grieger TA, Kluger MJ. Fever and survival: The role of serum iron. J Physiol 1978; 279: 187-196.
3. Weinberg ED. The iron-withholding defense system. ASM News 1993; 59: 559-562.
4. Perry RD. Acquisition and storage of inorganic iron and haemin by the Yersiniae. Trends Microbiol 1993; 1: 142-147.
5. Metchnikoff E. Immunity in infectious diseases, pp 175-206. Cambridge: Cambridge University Press, 1905.
6. Thomas EL, Lehrer RI, Rest RF. Human neutrophil antimicrobial activity. Rev Infect Dis 1988; 10 (suppl 2): S450-S456.
7. McNamara MP, Wiessner JH, Collins-Lech C, Hahn BL, Sohnle PG. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet 1988; 2: 1163-1165.
8. Murthy AR, Lehrer RI, Harwig SSL, Miyasaki KT. In vitro candidastatic properties of the human neutrophil Calprotectin complex. J Immunol 1993; 151: 6291-6301.
9. Sohnle PG, Collins-Lech C, Wiessner JH. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991; 163: 187-192.
10. Fagerhol M, Dale I, Andersson T. Release and quantitation of a leucocyte-derived protein (L1). Scand J Hematol 1980; 24: 393-398.
11. Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (The L1 Protein). In: Smith VL, Dedman JR, eds. Stimulus response coupling: the role of intracellular calcium-binding proteins, pp 187-210. Florida: CRC Press, 1990.
12. Miyasaki KT, Bodeau AL, Murthy ARK, Lehrer RI. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J Dent Res 1993; 72: 517-523.
13. Steinbakk M, Naess-Andresen CF, Lingass E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium-binding leucocyte L1 protein, calprotectin. Lancet 1990; 336: 763-765.
14. Lagasse E, Clerc RG. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol 1988; 8: 2402-2410.
15. Sander J, Fagerhol MK, Bakken JS, Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Lab Invest 1984; 44: 357-362.
16. Dorin JR, Novak M, Hill RE, Brock DJH, Secher DS, van Heyningen V. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987; 326: 614-617.
17. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol 1987; 87: 700-707.
18. Sohnle PG, Collins-Lech C, Wiessner JH. The zincreversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis 1991; 164: 137-142.
19. Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 1995; 42: 551-556.
20. Bamberger DM, Herndon BL, Suvarna PR. The effect of zinc on microbial growth and bacterial killing by cefazolin in a Staphyhcoccus aureus abscess milieu. J Infect Dis 1993; 168: 893-896.
21. Santhanagopalan V, Hahn BL, Dunn B, Wiessner JH, Sohnle PG. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. Clin Immunol Immunopathol 1995; 76: 285-290.
22. Brun JG, Ulvestad E, Fagerhol MK, Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol 1994; 40: 675-680.
23. Murao SI, Collart F, Huberman E. A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth. Cell Growth Differ 1990; 1: 447-454.
24. Devery JM, King NJC, Geczy CL. Acute inflammatory activity of the S100 protein CP-10. Activation of neutrophils in vivo and in vitro. J Immunol 1994; 152: 1888-1897.
25. Umekawa T, Kurita T. Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone. Biochem Mol Biol Int 1994; 34: 309-313.
26. 2+ on the assembly of brain microtubule proteins in vitro. FEBS Letters 1983; 163: 287-291.
27. Baudier J, Haglid K, Haiech J, Gerard D. Zinc ion binding to human brain calcium binding proteins, calmodulin and S100b protein. Biochem Biophys Res Comm 1983; 114: 1138-1148.
28. 2+ binding of S100b protein. J Biol Chem 1986; 261: 8192-8203.
29. Baudier J, Gerard D. Ions binding to S100 proteins: structural changes induced by calcium and zinc on S100a and S100b proteins. Biochem 1983; 22: 3360-3369.
30. Mehra RK, Tarbet EB, Gray WR, Winge DR. Metal-specific synthesis of two metallothioneins and γ-glutamyl peptides in Candida glabrata. Proc Nat Acad Sci USA 1988; 85: 8815-8819.
31. Failla ML. Zinc: functions and transport in microorganisms. In: Weinberg ED, ed. Microorganisms and minerals, pp 151-214. New York: Marcel Dekker, Inc., 1977.
32. Hsu JM. Biochemistry and metabolism of zinc. In: Karcioglu ZA, Sarper RM, eds. Zinc and copper in medicine, pp 66-93. Springfield: C.C. Thomas, 1980.
33. Vallee BL. Zinc - biochemistry, physiology, toxicology and clinical pathology. Biofactors 1988; 1: 31-36.
34. Berg JM, Shi Y. The galvanization of biology - a growing appreciation for the roles of zinc. Science 1996; 271: 1081-1085.
35. Sugarman B. Zinc and infection. Rev Infect Dis 1983; 5: 137-147.
36. Campo AG, McDonald CJ. Treatment of acrodermatitis enteropathica with zinc sulfate. Arch Dermatol 1976; 112: 687-689.
37. Santhanagopalan V, Hahn BL, Sohnle PG. Resistance of zinc-supplemented Candida albicans yeast cells to the growth-inhibitory effect of calprotectin. J Infect Dis 1995; 171: 1289-1294.
38. Sohnle PG, Hahn BL, Santhanagopalan V. Inhibition of Candida albicans growth by calprotectin in absence of direct contact with the organisms J Infect Dis 1996; 174: 1369-1372.
39. Muller F, Froland SS, Brandtzaeg P, Fagerhol MK. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis 1992; 16: 301-302.
40. Eversole LR, Miyasaki KT, Christensen RE. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med 1993; 22: 303-307.
41. Radke LL, Hahn BL, Wagner DK, Sohnle PG. Comparison of the metal-binding anticandidal activities of serum and abscess fluid supernatants. J Med Vet Mycol 1994; 32: 295-301.